efonidipine has been researched along with nitrophenols in 119 studies
Studies (efonidipine) | Trials (efonidipine) | Recent Studies (post-2010) (efonidipine) | Studies (nitrophenols) | Trials (nitrophenols) | Recent Studies (post-2010) (nitrophenols) |
---|---|---|---|---|---|
129 | 18 | 30 | 7,412 | 99 | 1,742 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 39 (32.77) | 18.2507 |
2000's | 43 (36.13) | 29.6817 |
2010's | 32 (26.89) | 24.3611 |
2020's | 5 (4.20) | 2.80 |
Authors | Studies |
---|---|
Kobayashi, M; Niwa, M; Nozaki, M; Tsurumi, K | 1 |
Masuda, Y; Sakai, T; Tanaka, S; Tomita, K; Yokoyama, T | 1 |
Kamikawaji, Y; Sakoda, R; Seto, K | 1 |
Matsumoto, H; Sakoda, R; Seto, K | 1 |
Hoshino, T; Kaburagi, T; Mori, N; Sakata, K; Yokoyama, S; Yoshida, H | 1 |
Kokubun, S; Saigusa, A; Tamura, T | 1 |
Kasuya, Y; Masuda, Y; Sakai, T; Tanaka, S; Yamashita, T | 2 |
Hongo, K; Kurihara, S; Tanaka, E; Tanaka, T | 1 |
Furuichi, H; Ito, S; Izumi, J; Kurimoto, T; Matsumura, T; Mori, T; Nishi, N; Suda, H; Takei, M; Tanaka, Y | 1 |
Masuda, Y; Shudo, C; Sugita, H; Tanaka, S; Yamashita, T; Yotsumoto, T | 1 |
Kasuya, Y; Masuda, Y; Miyajima, M; Shigenobu, K; Shudo, C; Tanaka, S | 1 |
Furukawa, S; Hayashi, K; Hirata, H; Masuda, Y; Shudo, C; Sugita, H; Tanaka, S; Tomita, K | 1 |
Furukawa, S; Hayashi, K; Hirata, H; Masuda, Y; Shudo, C; Tamura, T; Yamamoto, O | 1 |
Masuda, Y; Shudo, C; Sugita, H; Tanaka, S; Tomita, K | 1 |
Kasuya, Y; Masuda, Y; Sakai, T; Shigenobu, K; Shudo, C; Tanaka, S | 2 |
Kitahara, M; Masuda, Y; Saito, Y; Sakashita, M; Shudo, C; Tanaka, S; Toyoda, K; Yamashita, T | 1 |
Higashino, R; Ito, S; Kurimoto, T; Matsuda, K; Takei, M; Tanaka, T | 1 |
Kitahara, M; Saito, Y; Sakashita, M; Tanaka, S; Toyoda, K; Yamashita, T | 1 |
Kamikawaji, Y; Nakabeppu, H; Nakajima, A; Shinozaki, Y | 1 |
Masumiya, H; Saito, W; Sekine, T; Shigenobu, K; Sijuku, T; Sugahara, M; Tanaka, H; Taniguchi, H; Terada, M | 1 |
Fujikura, N; Masuda, Y; Shikada, K; Tanaka, S; Yokoyama, T | 3 |
Asada, M; Nakabeppu, H; Oda, T; Shinozaki, Y; Yajima, T | 1 |
Furukawa, S; Hayashi, K; Hirata, H; Masuda, Y; Shikada, K; Shudo, C; Sugita, H; Tamura, T; Tanaka, S; Tomita, K | 1 |
Fujii, K; Ichikawa, H; Inagaki, Y; Iwata, J; Karaki, A; Kobayashi, S; Kuwabara, Y; Saito, T; Takeda, K; Takizawa, T; Tomiya, H; Toyosaki, T; Yamada, K; Yamazaki, Y | 1 |
Abiko, Y; Ichihara, K; Yokoyama, T | 2 |
Fukuda, Y; Higashino, R; Jin, H; Kurimoto, T; Sato, R; Tamaki, H | 1 |
Fukuta, Y; Higashino, R; Inoue, N; Jin, H; Kurimoto, T; Sato, R; Tamaki, H | 1 |
Masumiya, H; Shigenobu, K; Tanaka, H | 1 |
Matsuoka, T; Nishizaki, T; Nomura, T | 1 |
Shou, I; Takeda, M; Tomino, Y | 1 |
Fujiwara, K; Hayashi, K; Kanno, Y; Saruta, T; Takenaka, T | 1 |
Masumiya, H; Shigenobu, K; Shijuku, T; Tanaka, H | 1 |
Han, WH; Kawabata, M; Ogawa, T; Takabatake, T | 1 |
Kaneko, S; Shou, I; Takeda, M; Takizawa, H; Tomino, Y | 1 |
Masumiya, H; Matsuda, T; Shigenobu, K; Tanaka, H; Tanaka, Y | 1 |
Hayashi, M; Nakazato, Y; Saruta, T; Yamaji, Y | 1 |
Fujimori, T; Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y; Watanabe, S | 1 |
Kase, J; Masumiya, H; Shigenobu, K; Tanaka, H; Tanaka, Y | 1 |
Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Tokuyama, H | 1 |
Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Takamatsu, I; Tokuyama, H | 1 |
Shigenobu, K; Tanaka, H | 2 |
Fukuhara, S; Kanazawa, S; Nomura, S | 1 |
Gemba, M; Kohda, Y; Nakamura, M; Notoya, M; Takashita, Y; Yamashita, J | 1 |
Harada, K; Ito, S; Nakaya, Y; Nishikado, A; Nomura, M; Uehara, K | 1 |
Hayashi, K; Kumagai, H; Saruta, T | 1 |
Fukuda, Y; Hara, M; Kinebuchi, O; Kurita, Y; Mitamura, H; Miyoshi, S; Ogawa, S; Ohashi, N; Shiroshita-Takeshita, A; Takatsuki, S; Tanimoto, K | 1 |
Furukawa, T; Honda, M; Isshiki, T; Kamiya, N; Miura, R; Mori, Y; Nukada, T; Takeshita, S | 1 |
Kawanishi, T; Komikado, C; Namekata, I; Shigenobu, K; Shimada, H; Takeda, K; Tanaka, H | 1 |
Hayashi, K; Homma, K; Saruta, T; Sugano, N; Wakino, S | 1 |
Hasegawa, K; Hayashi, K; Homma, K; Kanda, T; Sugano, N; Takamatsu, I; Tatematsu, S; Wakino, S; Yoshioka, K | 1 |
Horii, M; Imagawa, K; Kawata, H; Nakajima, T; Naya, N; Okayama, S; Saito, Y; Takaoka, M; Uemura, S | 1 |
Higashi, Y; Ishida, M; Ishida, T; Kambe, M; Miho, N; Oshima, T; Ozono, R; Teragawa, H; Yano, Y; Yoshizumi, M | 1 |
Hadama, T; Kaku, T; Lee, TS; Miyamoto, S; Ono, K; Perez-Reyes, E; Takebayashi, S; Uchino, T | 1 |
Goto, Y; Ishii, M | 1 |
Horii, M; Imagawa, K; Iwama, H; Kawata, H; Nakajima, T; Naya, N; Okayama, S; Saito, Y; Somekawa, S; Uemura, S | 1 |
Ikeda, J; Matsubara, M; Yao, K | 1 |
Ahn, JY; Chung, WJ; Han, SH; Kim, JA; Koh, KK; Lee, SJ; Lee, Y; Quon, MJ; Shin, EK | 1 |
Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Numabe, A; Ohta, S; Ono, H; Takahashi, T; Yoshii, M | 1 |
Fujii, M; Horie, M; Sakai, H; Tanaka, T; Tsutamoto, T; Yamamoto, T | 1 |
Matsuzaki, M; Ohkusa, T; Ono, K; Sato, T; Suzuki, S; Takebayashi, S; Yano, M; Yoshida, MA | 1 |
Hara, Y; Hasegawa, K; Hayashi, K; Homma, K; Hosoya, T; Kanda, T; Saruta, T; Suetsugu, Y; Sugano, N; Tatematsu, S; Tokudome, G; Utsunomiya, Y; Wakino, S; Yoshioka, K; Yoshizawa, T | 1 |
Hojo, M; Horiba, M; Kamiya, K; Kodama, I; Lee, JK; Miwa, K; Muto, T; Opthof, T; Ueda, N; Yasui, K | 1 |
Akaike, N; Kim, CJ; Min, BI; Ogawa, S; Shin, MC; Tanaka, E | 1 |
Komikado, C; Nakamura, H; Namekata, I; Shigenobu, K; Suzuki, M; Takahara, A; Tanaka, H; Tsuneoka, Y | 1 |
Wang, N; Ye, L; Yu, JX; Zhao, BQ | 1 |
Perez-Reyes, E; Van Deusen, AL; Vitko, I | 1 |
Ikeda, K; Inada, Y; Isaka, T; Tajima, N; Takada, Y; Tojo, K | 1 |
Iwasaka, T; Jo, F; Maki, K; Morimoto, S | 1 |
Mitamura, H; Ogawa, S; Ohashi, N | 1 |
Ball, CJ; Beltrame, JF; Saint, DA; Turner, SP; Wilson, DP | 1 |
Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tanaka, T; Tsutamoto, T; Yamaji, M; Yamamoto, T | 1 |
Adachi-Akahane, S; Akaike, T; Ishikawa, Y; Iwamoto, M; Iwasaki, S; Izumi-Nakaseko, H; Jiao, Q; Jin, MH; Kamiya, Y; Minamisawa, S; Nishimaki, S; Sato, M; Yokota, S; Yokoyama, U | 1 |
Arai, Y; Fujiwara, M; Harada, M; Kinoshita, H; Kuwabara, Y; Kuwahara, K; Murakami, M; Nakagawa, Y; Nakanishi, M; Nakao, K; Takano, M; Ueshima, K; Yasuno, S | 1 |
Ban, N; Endo, K; Kawana, H; Miyashita, Y; Nagayama, D; Ohhira, M; Oyama, T; Saiki, A; Sasaki, H; Shirai, K; Yamaguchi, T | 1 |
Fukushima, R; Hirose, H; Koyama, H; Machida, N; Matsumoto, H; Tanaka, R; Yamane, Y | 1 |
Adachi, M; Aritomi, S; Hayata, M; Kakizoe, Y; Kitamura, K; Ko, T; Konda, T; Miyoshi, T; Shiraishi, N; Tomita, K; Uchimura, K; Wakida, N | 1 |
Jin, D; Miyazaki, M; Sakonjo, H; Takai, S | 1 |
Inada, H; Ishimitsu, T; Matsuoka, H; Nakano, N; Ohba, S; Okamura, A; Takahashi, T | 1 |
Goto, Y; Ishii, M; Ogihara, T; Rakugi, H | 1 |
Okura, T | 1 |
Goto, Y; Hayashi, K; Ishii, M; Saruta, T | 1 |
Adachi-Akahane, S; Iida-Tanaka, N; Izumi-Nakaseko, H; Komikado, C; Namekata, I; Ogawa, T; Takahara, A; Tanaka, H; Tsuneoka, Y; Tsuru, H | 1 |
Ito, S | 1 |
Hayashi, K; Homma, K; Itoh, H; Saruta, T; Sugano, N; Tokuyama, H; Wakino, S | 1 |
Hayashi, T; Inoue, T; Ishizaka, N; Kitada, K; Kitaura, Y; Kurumazuka, D; Matsuda, H; Matsumura, Y; Mori, T; Nagatoya, K; Ukimura, A | 1 |
Huang, CS; Kuo, CC; Pan, MK; Tai, CH; Yang, YC | 1 |
Ikeda, K; Saito, T; Tojo, K | 1 |
Goto, Y; Ishii, M; Kawano, Y; Ogihara, T; Saruta, T | 1 |
Deguchi, K; Hitomi, H; Kitaura, Y; Kobori, H; Lei, B; Masaki, T; Mori, H; Mori, T; Nagai, Y; Nakano, D; Nishiyama, A | 1 |
Ninomiya, T | 1 |
Choi, DH; Choi, JS; Li, C | 1 |
Chattipakorn, N; Chattipakorn, S; Chinda, K; Fucharoen, S; Kumfu, S | 1 |
Chang, CJ; Dickinson, BC; Guo, Q; Hu, C; Ito, S; Lu, Y; Miyata, T; Mori, T; Nakamichi, T; Oba, I; Ogawa, S; Ohsaki, Y; Sato, E; Sato, H; Sun, Y; Yoneki, Y | 1 |
Fujita, M; Ikai, A; Mitani, S; Miyamoto, S; Ogura, C; Ono, K; Sugimoto, N; Tanaka, S | 1 |
Chattipakorn, N; Chattipakorn, S; Fucharoen, S; Kumfu, S | 1 |
Bub, G; Herzlinger, D; Hurtado, R | 1 |
Han, J; Liu, H; Liu, M; Tong, Y; Wang, X; Zhang, D; Zhang, L; Zhao, H | 1 |
Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Kumfu, S | 1 |
Deng, M; Liu, H; Liu, M; Ma, J; Tong, Y; Wang, X; Zhang, D; Zhang, L; Zhao, H | 1 |
Fukami, T; Inoue, M; Maeno, Y; Otsuka, M; Ozeki, T; Tagami, T | 1 |
Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Jaiwongkam, T; Kerdphoo, S; Khamseekaew, J; Kumfu, S; Srichairatanakool, S; Wongjaikam, S | 1 |
Asayama, K; Hanazawa, T; Hosaka, M; Imai, Y; Inoue, R; Obara, T; Ohkubo, T; Satoh, M; Watabe, D | 1 |
Cheng, G; Huang, S; Li, H; Piao, H; Sun, Y; Zhang, Q; Zou, M | 1 |
Huang, Y; Shen, J; Tang, L; Xiong, W; Xu, F; Zhou, D | 1 |
Cherian, JJ; Davis, S; Raju, AR; Thomas, E | 1 |
Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Khamseekaew, J; Srichairatanakool, S; Sripetchwandee, J; Svasti, S | 1 |
Jha, UC; Narayan, A | 1 |
Cheng, G; Cheng, X; Gao, J; Li, J; Piao, H; Zou, M | 1 |
Hara, N; Hashimoto, K; Kawakami, H; Maruyama, H; Matsuda, Y; Morino, H; Satoh, K | 1 |
Abohashrh, M; Ahmad, I; Alam, MM; Baig, MH; Dong, JJ; Sharma, T | 1 |
Ashraf, GM; Barreto, GE; Chavda, V; Patel, SS; Rajput, R | 1 |
7 review(s) available for efonidipine and nitrophenols
Article | Year |
---|---|
Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
Topics: Animals; Biological Clocks; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Humans; Muscle, Smooth, Vascular; Myocardial Contraction; Nitrophenols; Organophosphorus Compounds | 2002 |
Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug development.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Drug Design; Humans; Mibefradil; Nitrophenols; Organophosphorus Compounds | 2005 |
Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Dihydropyridines; Humans; Kidney; Kidney Diseases; Microcirculation; Nitrophenols; Organophosphorus Compounds; Renal Circulation; Signal Transduction | 2005 |
[JATOS].
Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Japan; Male; Nitrophenols; Organophosphorus Compounds; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Single-Blind Method | 2006 |
Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Drug Delivery Systems; Humans; Nitrophenols; Organophosphorus Compounds | 2009 |
T-type Ca channel blockade as a determinant of kidney protection.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Dihydropyridines; Humans; Kidney Diseases; Nitrophenols; Organophosphorus Compounds | 2010 |
Efonidipine-Induced Exanthematic Drug Eruption and Literature Review.
Topics: Administration, Cutaneous; Administration, Oral; Aged, 80 and over; Calcium Channel Blockers; Dihydropyridines; Drug Eruptions; Exanthema; Female; Glucocorticoids; Histamine Antagonists; Humans; Nitrophenols; Organophosphorus Compounds; Skin; Treatment Outcome | 2019 |
18 trial(s) available for efonidipine and nitrophenols
Article | Year |
---|---|
Plasma and urinary metabolites of efonidipine hydrochloride in man.
Topics: Adult; Animals; Biotransformation; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Dihydropyridines; Dogs; Humans; Male; Mass Spectrometry; Nitrophenols; Organophosphorus Compounds; Rats; Species Specificity | 1996 |
Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina.
Topics: Angina Pectoris; Area Under Curve; Calcium Channel Blockers; Cardiac Output; Central Venous Pressure; Dihydropyridines; Electrocardiography; Exercise; Exercise Test; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Radionuclide Imaging; Rest; Stroke Volume; Vascular Resistance | 1996 |
Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus.
Topics: Aged; Antihypertensive Agents; Blood Cell Count; Cell Adhesion Molecules; Diabetes Mellitus, Type 2; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Monocytes; Nitrophenols; Organophosphorus Compounds; Platelet Activation; Vascular Diseases | 2002 |
Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Proteinuria | 2003 |
The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): protocol, patient characteristics, and blood pressure during the first 12 months.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Female; Humans; Hypertension; Japan; Male; Nitrophenols; Organophosphorus Compounds; Prospective Studies; Treatment Outcome | 2005 |
Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
Topics: Adult; Aged; Blood Flow Velocity; Brachial Artery; Calcium Channel Blockers; Case-Control Studies; Dihydropyridines; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nitrophenols; Organophosphorus Compounds; Vasodilation | 2005 |
Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Calcium Channel Blockers; Calcium Channels, T-Type; Cross-Over Studies; Depression, Chemical; Dihydropyridines; Hemodynamics; Humans; Male; Neurotransmitter Agents; Nifedipine; Nitrophenols; Organophosphorus Compounds; Renin; Water-Electrolyte Balance | 2006 |
Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
Topics: Adiponectin; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cholesterol, HDL; Dihydropyridines; Endothelium, Vascular; Humans; Hypertension; Leptin; Nitrophenols; Organophosphorus Compounds; Placebos; Vasodilation | 2007 |
Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Topics: Adult; Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Chronic Disease; Cross-Over Studies; Dihydropyridines; Female; Glomerulonephritis; Humans; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Proteinuria | 2007 |
Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
Topics: Aged; Aged, 80 and over; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Nitrophenols; Norepinephrine; Organophosphorus Compounds | 2007 |
Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
Topics: Aged; Aged, 80 and over; Aging; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Diuretics; Dose-Response Relationship, Drug; Endpoint Determination; Female; Humans; Hypertension; Japan; Male; Nitrophenols; Organophosphorus Compounds; Single-Blind Method; Systole | 2008 |
Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Topics: Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Natriuretic Peptide, Brain; Nitrophenols; Organophosphorus Compounds; Renin; Time Factors | 2009 |
Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aldosterone; Amlodipine; Arteries; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Female; Glycated Hemoglobin; Humans; Hypertension; Kidney; Lipids; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds | 2009 |
Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
Topics: Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cross-Over Studies; Dihydropyridines; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Renal Dialysis; Renin-Angiotensin System | 2010 |
Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cardiovascular Diseases; Chronic Disease; Dihydropyridines; Female; Humans; Hypertension; Kidney; Kidney Diseases; Male; Nitrophenols; Organophosphorus Compounds; Prospective Studies | 2010 |
Association of blood pressure control and metabolic syndrome with cardiovascular risk in elderly Japanese: JATOS study.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Asian People; Blood Pressure; Cardiovascular Diseases; Dihydropyridines; Female; Humans; Hypertension; Japan; Male; Metabolic Syndrome; Nitrophenols; Organophosphorus Compounds; Prevalence; Risk Factors | 2011 |
L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Topics: Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cross-Over Studies; Dihydropyridines; Female; Heart; Heart Conduction System; Hemodynamics; Humans; Hypertension; Male; Nitrophenols; Norepinephrine; Organophosphorus Compounds; Prospective Studies; Sympathetic Nervous System | 2012 |
Effect of amlodipine, efonidipine, and trichlormethiazide on home blood pressure and upper-normal microalbuminuria assessed by casual spot urine test in essential hypertensive patients.
Topics: Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Irbesartan; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Tetrazoles; Trichlormethiazide; Urinalysis | 2018 |
94 other study(ies) available for efonidipine and nitrophenols
Article | Year |
---|---|
[Affinity of Z-105 to the 1,4-dihydropyridine type calcium channel and several other receptor bindings in the central nervous system].
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Diltiazem; In Vitro Techniques; Male; Nicardipine; Nitrophenols; Organophosphorus Compounds; Radioligand Assay; Rats; Receptors, Neurotransmitter; Tritium | 1992 |
Effects of NZ-105, a new calcium antagonist, on renal function in anesthetized spontaneously hypertensive rats.
Topics: Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Electrolytes; Glomerular Filtration Rate; Kidney; Kidney Function Tests; Kidney Tubules; Lithium; Male; Nicardipine; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Inbred SHR; Renal Circulation; Urodynamics | 1992 |
Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrop
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Crystallization; Dihydropyridines; In Vitro Techniques; Nitrophenols; Organophosphorus Compounds; Rats; X-Ray Diffraction | 1992 |
Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Crystallization; Dihydropyridines; In Vitro Techniques; Molecular Conformation; Nitrophenols; Organophosphorus Compounds; Rats; Stereoisomerism; X-Ray Diffraction | 1992 |
[Antihypertensive effects and pharmacokinetics of NZ-105 single administration in patients with hypertension].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds | 1992 |
Mechanisms underlying the slow onset of action of a new dihydropyridine, NZ-105, on a cultured smooth muscle cell line.
Topics: Animals; Antihypertensive Agents; Calcium Channels; Cell Line; Dihydropyridines; Electric Stimulation; Electrophysiology; Membrane Potentials; Muscle, Smooth, Vascular; Nitrophenols; Organophosphorus Compounds; Rats | 1991 |
NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta.
Topics: Animals; Antihypertensive Agents; Aorta; Binding, Competitive; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Radioisotopes; Dihydropyridines; In Vitro Techniques; Kinetics; Male; Membranes; Microsomes; Muscle, Smooth, Vascular; Nitrendipine; Nitrophenols; Organophosphorus Compounds; Rabbits; Receptors, Nicotinic; Time Factors; Tritium | 1991 |
Effects of a newly synthesized dihydropyridine, NZ-105, on intracellular Ca transients and tension in ferret ventricular muscles.
Topics: Animals; Calcium; Dihydropyridines; Ferrets; In Vitro Techniques; Myocardial Contraction; Nitrophenols; Organophosphorus Compounds; Papillary Muscles; Vasodilator Agents | 1994 |
[Effect of efonidipine hydrochloride, a calcium channel blocker, on the experimental cerebral ischemia/anoxia].
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Dihydropyridines; Flunarizine; Hypoxia; Male; Mice; Mice, Inbred ICR; Nicardipine; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Wistar | 1995 |
Effects of efonidipine hydrochloride (NZ-105), a calcium antagonist, on renal function in conscious spontaneously hypertensive rats.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Administration Schedule; Hypertension, Renal; Kidney; Male; Nitrophenols; Organophosphorus Compounds; Potassium; Rats; Rats, Inbred SHR; Renal Circulation; Sodium | 1995 |
Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Atrial Function; Calcium Channel Blockers; Depression, Chemical; Dihydropyridines; Guinea Pigs; Heart; Heart Atria; Heart Rate; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Contraction; Nicardipine; Nitrophenols; Organophosphorus Compounds; Rabbits | 1995 |
Inhibitory effect of NZ-105, a 1,4-dihydropyridine derivative, on cyclic nucleotide phosphodiesterase activity.
Topics: 1-Methyl-3-isobutylxanthine; 2',3'-Cyclic-Nucleotide Phosphodiesterases; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Aorta, Thoracic; Calcium Channel Blockers; Cattle; Cyclic AMP; Cyclic GMP; Dihydropyridines; In Vitro Techniques; Intracellular Fluid; Male; Myocardium; Nicardipine; Nitrophenols; Organophosphorus Compounds; Rabbits | 1993 |
Renal protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Calcium Channel Blockers; Dihydropyridines; Hypertension; Kidney; Male; Nitrophenols; Organ Size; Organophosphorus Compounds; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
Influence of efonidipine hydrochloride, calcium antagonist on the epithelium of prostates in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Epithelium; Hypertension; Male; Nitrophenols; Organophosphorus Compounds; Prostate; Rats; Rats, Inbred SHR | 1994 |
Effects of efonidipine hydrochloride (NZ-105), a new calcium antagonist, against acute renal failure in rats.
Topics: Acute Kidney Injury; Animals; Calcium Channel Blockers; Dihydropyridines; Diuretics; Free Radical Scavengers; Free Radicals; Glycerol; Ischemia; Kidney; Lipid Peroxidation; Male; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Rats, Wistar | 1994 |
Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats.
Topics: Administration, Oral; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Heart; Heart Rate; Hypertension; Kidney; Liver; Male; Nitrophenols; Organ Size; Organophosphorus Compounds; Propranolol; Rats; Rats, Inbred SHR; Renin; Time Factors | 1993 |
[Effect of efonidipine hydrochloride (NZ-105), a new dihydropyridine calcium antagonist, on the experimental atherosclerosis in cholesterol-fed rabbits].
Topics: Animals; Aorta; Aortic Diseases; Arteriosclerosis; Calcium; Cholesterol; Cholesterol, Dietary; Diet, Atherogenic; Dihydropyridines; Lipids; Nitrophenols; Organophosphorus Compounds; Rabbits | 1994 |
Studies on the hypotensive mechanisms of NZ-105, a new dihydropyridine derivative, in rats and rabbits.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Decerebrate State; Dihydropyridines; Male; Nicardipine; Nitrophenols; Organophosphorus Compounds; Posture; Rabbits; Rats; Rats, Inbred SHR; Rats, Wistar | 1993 |
[Effect of efonidipine hydrochloride (NZ-105) on modification of low density lipoprotein induced by rat cultured endothelial cells].
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Cells, Cultured; Depression, Chemical; Dihydropyridines; Dose-Response Relationship, Drug; Endothelium; Lipoproteins, LDL; Male; Nisoldipine; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Wistar | 1995 |
Effects of efonidipine hydrochloride on cholesterol esterification mediated by beta-very low density lipoprotein in J774 macrophages.
Topics: Animals; Binding, Competitive; Calcium Channel Blockers; Cholesterol; Cyclic AMP; Dihydropyridines; Dose-Response Relationship, Drug; Esterification; Lipoproteins, VLDL; Macrophages; Mice; Nicardipine; Nitrophenols; Organophosphorus Compounds; Radioligand Assay | 1995 |
Identification of efonidipine hydrochloride metabolites in rats.
Topics: Administration, Oral; Animals; Bile; Biotransformation; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Dihydropyridines; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley | 1995 |
Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Nitrophenols; Organophosphorus Compounds; Potassium Chloride; Rats; Rats, Wistar; Verapamil | 1996 |
[Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
Topics: Anesthesia; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Dogs; Female; Heart Rate; Male; Myocardium; Nifedipine; Nisoldipine; Nitrophenols; Organophosphorus Compounds; Oxygen Consumption; Thoracotomy | 1996 |
Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Captopril; Creatinine; Dihydropyridines; Heart Rate; Hypertension; Kidney; Male; Nicardipine; Nitrophenols; Organophosphorus Compounds; Proteinuria; Rats; Rats, Inbred SHR | 1996 |
[Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Dogs; Myocardium; Nifedipine; Nisoldipine; Nitrophenols; Organophosphorus Compounds; Oxygen Consumption; Partial Pressure | 1996 |
Efonidipine, a long-acting dihydropyridine derivative, attenuates coronary vasoconstriction induced by endothelin-1 in dogs.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Coronary Angiography; Coronary Vessels; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Endothelin-1; Female; Heart Rate; Male; Nitrophenols; Organophosphorus Compounds; Vasodilation | 1996 |
[Effects of efonidipine hydrochloride, a calcium antagonist derived from dihydropyridine, on acute myocardial ischemia in anesthetized open-chest dogs].
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Dihydropyridines; Dogs; Female; Hemodynamics; Male; Myocardial Ischemia; Nitrophenols; Organophosphorus Compounds; Oxygen Consumption; Regional Blood Flow; Vascular Resistance | 1996 |
Spasmolytic effect of efonidipine hydrochloride in isolated canine coronary artery: comparison with the effects of nifedipine and nisoldipine.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4-Aminopyridine; Amifampridine; Animals; Arteries; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Dogs; In Vitro Techniques; Nitrophenols; Organophosphorus Compounds; Potassium; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstrictor Agents | 1997 |
Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: comparison with effects of nifedipine and nisoldipine.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Binding, Competitive; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Endothelin-1; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nisoldipine; Nitrophenols; Organophosphorus Compounds; Potassium; Prostaglandin Endoperoxides, Synthetic; Serotonin; Swine; Thromboxane A2; Vasoconstrictor Agents | 1997 |
Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine.
Topics: Animals; Calcium Channel Blockers; Carbohydrate Metabolism; Dihydropyridines; Dogs; Energy Metabolism; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardium; Nifedipine; Nitrophenols; Organophosphorus Compounds | 1997 |
Effects of Ca2+ channel antagonists on sinus node: prolongation of late phase 4 depolarization by efonidipine.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Dihydropyridines; Male; Nitrophenols; Organophosphorus Compounds; Rabbits; Sinoatrial Node | 1997 |
The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
Topics: Animals; Barium; Brain; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Carotid Arteries; Cattle; Cells, Cultured; Cerebral Arteries; Dihydropyridines; Membrane Potentials; Muscle, Smooth, Vascular; Nicardipine; Nitrophenols; Organophosphorus Compounds; Patch-Clamp Techniques; Time Factors | 1997 |
Effects of the antihypertensive drug efonidipine hydrochloride on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes.
Topics: Albuminuria; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Dihydropyridines; Hypertension; Kidney; Male; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Streptozocin | 1998 |
Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Hypertension; Kidney; Male; Nephrectomy; Nitrophenols; Organophosphorus Compounds; Proteinuria; Rats; Rats, Inbred SHR; Systole | 1998 |
Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels; Depression, Chemical; Dihydropyridines; Female; Guinea Pigs; Heart; Heart Rate; Male; Myocardial Contraction; Nifedipine; Nitrophenols; Organophosphorus Compounds; Patch-Clamp Techniques; Potassium Channels; Sinoatrial Node | 1998 |
Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Glomerular Filtration Rate; Kidney; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Nitrophenols; Organophosphorus Compounds; Proteinuria; Rats; Rats, Inbred SHR; Renal Circulation | 1999 |
Effects of the antihypertensive drug nifedipine on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes.
Topics: Albuminuria; Animals; Antihypertensive Agents; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dihydropyridines; Kidney; Male; Nifedipine; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Inbred SHR; Time Factors; Vasodilator Agents | 1999 |
Possible requirement of phosphonate moiety for efonidipine effects on the sino-atrial node action potential.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Dihydropyridines; Male; Nicardipine; Nitrophenols; Organophosphorus Compounds; Rabbits; Sinoatrial Node; Structure-Activity Relationship | 2000 |
The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcimycin; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Carcinogens; Cells, Cultured; Dihydropyridines; Gene Expression; Genes, Reporter; Glomerular Mesangium; Humans; Ionophores; Luciferases; NF-kappa B; Nifedipine; Nitrophenols; Organophosphorus Compounds; Tetradecanoylphorbol Acetate; Verapamil | 2000 |
Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
Topics: Animals; Apoptosis; Calcium Channel Blockers; Cell Count; Dihydropyridines; Enzyme Inhibitors; Kidney Glomerulus; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitrophenols; Organophosphorus Compounds; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred SHR | 2000 |
Frequency-dependent blockade of T-type Ca2+ current by efonidipine in cardiomyocytes.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, T-Type; Dihydropyridines; Electric Stimulation; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Membrane Potentials; Myocardium; Nitrophenols; Organophosphorus Compounds; Patch-Clamp Techniques; Ventricular Function | 2000 |
Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Male; Mibefradil; Natriuresis; Nifedipine; Nitric Oxide; Nitrophenols; Organophosphorus Compounds; Prostaglandins; Renal Circulation | 2001 |
Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Dogs; Hemodynamics; Mibefradil; Microcirculation; Nifedipine; Nitrophenols; Organophosphorus Compounds; Renal Circulation; Vasodilation | 2001 |
Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats.
Topics: Animals; Arterioles; Blood Pressure; Body Weight; Calcium Channel Blockers; Corrosion Casting; Dihydropyridines; Hypertension, Renal; Kidney Glomerulus; Male; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Inbred SHR; Renal Circulation | 2002 |
Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Topics: 3-Iodobenzylguanidine; Adult; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Electrocardiography; Female; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Iodine Radioisotopes; Male; Nitrophenols; Organophosphorus Compounds; Radionuclide Imaging; Spectrum Analysis; Sympathetic Nervous System; Tachycardia; Treatment Outcome | 2003 |
A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling.
Topics: Administration, Oral; Animals; Atrial Fibrillation; Atrioventricular Node; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiac Pacing, Artificial; Dihydropyridines; Dogs; Electrophysiology; Forecasting; Heart Atria; Japan; Male; Nitrophenols; Organophosphorus Compounds; Refractory Period, Electrophysiological; Research Design; Time Factors; Verapamil | 2004 |
Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Cell Line; Cricetinae; Dihydropyridines; Dose-Response Relationship, Drug; Female; Nitrophenols; Organophosphorus Compounds; Stereoisomerism; Xenopus | 2004 |
The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Guinea Pigs; Heart; Heart Ventricles; Nitrophenols; Organophosphorus Compounds; Stereoisomerism | 2004 |
Divergent action of calcium channel blockers on ATP-binding cassette protein expression.
Topics: Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dihydropyridines; Humans; Hypertension; Janus Kinase 2; Nitrophenols; Organophosphorus Compounds; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; RNA, Messenger | 2005 |
Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
Topics: Adrenal Gland Neoplasms; Aldosterone; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line, Tumor; Cytochrome P-450 CYP11B2; Dihydropyridines; Humans; Nitrophenols; Organophosphorus Compounds; RNA, Messenger | 2006 |
Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
Topics: Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Dihydropyridines; Humans; Mibefradil; Nifedipine; Nitrophenols; Organophosphorus Compounds; Recombinant Proteins | 2006 |
Effects of benidipine in a rat model for experimental angina.
Topics: Amlodipine; Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Male; Nifedipine; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Inbred Strains | 2006 |
Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiomyopathies; Cricetinae; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiology; Female; Heart Rate; Male; Mesocricetus; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitrophenols; Organophosphorus Compounds; Patch-Clamp Techniques | 2007 |
T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Chronic Disease; Dihydropyridines; Hypertension; Kidney Diseases; Male; Nephrectomy; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Inbred SHR | 2008 |
T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
Topics: Active Transport, Cell Nucleus; Animals; Calcineurin; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cattle; Cells, Cultured; Dihydropyridines; Hypertrophy; Mice; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Neurotoxins; NFATC Transcription Factors; Nisoldipine; Nitrophenols; Organophosphorus Compounds; Patch-Clamp Techniques; Scorpion Venoms | 2008 |
A selective T-type Ca2+ channel blocker R(-) efonidipine.
Topics: Animals; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, T-Type; Dihydropyridines; Dose-Response Relationship, Drug; Flunarizine; Mibefradil; Nitrophenols; Nystatin; Organophosphorus Compounds; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Pyramidal Cells; Rats; Rats, Wistar; Sodium Channels | 2008 |
Species difference in the contribution of T-type calcium current to cardiac pacemaking as revealed by r(-)-efonidipine.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Dihydropyridines; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Mice; Microelectrodes; Nitrophenols; Organophosphorus Compounds; Rabbits; Sinoatrial Node; Species Specificity; Time Factors | 2008 |
Spectroscopic studies on the interaction of efonidipine with bovine serum albumin.
Topics: Animals; Cattle; Circular Dichroism; Dihydropyridines; Models, Chemical; Nitrophenols; Organophosphorus Compounds; Serum Albumin, Bovine; Spectrometry, Fluorescence; Thermodynamics | 2008 |
Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Cells, Cultured; Dihydropyridines; Humans; Mibefradil; Nitrophenols; Organophosphorus Compounds; Verapamil | 2009 |
Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Angiotensin II; Azetidinecarboxylic Acid; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line, Tumor; Cytochrome P-450 CYP11B2; Dihydropyridines; Gene Expression Regulation; Humans; Nitrophenols; Organophosphorus Compounds; Potassium Chloride; Steroid 11-beta-Hydroxylase | 2009 |
Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Dihydropyridines; Heart Rate; Humans; Male; Nitrophenols; Organophosphorus Compounds; Stress, Physiological; Stress, Psychological | 2009 |
Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.
Topics: Animals; Aorta; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Humans; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Mibefradil; Microvessels; Nifedipine; Nitrophenols; Organophosphorus Compounds; Potassium Chloride; Rats; Rats, Sprague-Dawley; Subcutaneous Fat; Vasoconstriction; Verapamil | 2009 |
T-type Ca2+ channels promote oxygenation-induced closure of the rat ductus arteriosus not only by vasoconstriction but also by neointima formation.
Topics: Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Dihydropyridines; Ductus Arteriosus; Muscle, Smooth, Vascular; Nitrophenols; Organ Culture Techniques; Organophosphorus Compounds; Protein Isoforms; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Vasoconstriction | 2009 |
T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Body Weight; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Dihydropyridines; Disease Models, Animal; Female; Mibefradil; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Infarction; Myocytes, Cardiac; Nitrendipine; Nitrophenols; Organophosphorus Compounds; Patch-Clamp Techniques | 2009 |
Effects of enfonidipine hydrochloride in dogs with experimental supraventricular tachyarrhythmia.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Dog Diseases; Dogs; Heart Rate; Humans; Nitrophenols; Organophosphorus Compounds; Systole; Tachycardia; Tachycardia, Supraventricular; Treatment Outcome | 2010 |
Regulation of adrenal aldosterone production by serine protease prostasin.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Channel Blockers; Cell Line; Cytochrome P-450 CYP11B2; Dihydropyridines; Gene Expression Regulation; Gene Silencing; Humans; Nitrophenols; Organophosphorus Compounds; Promoter Regions, Genetic; Rats; Receptors, Proteinase-Activated; Recombinant Proteins; Serine Endopeptidases; Tetrazoles; Transfection; Valine; Valsartan | 2010 |
Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Chemokine CCL2; Collagen Type I; Dihydropyridines; Drug Therapy, Combination; Gene Expression; Glomerulosclerosis, Focal Segmental; Hypertension; Irbesartan; Kidney Glomerulus; Male; NADPH Oxidases; Nitrophenols; Organophosphorus Compounds; Proteinuria; Rats; Rats, Inbred Dahl; Tetrazoles; Transforming Growth Factor beta | 2010 |
Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOS.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Dihydropyridines; Female; Humans; Hypertension; Incidence; Japan; Male; Nitrophenols; Organophosphorus Compounds; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Efonidipine improves renal function and decreases proteinuria in elderly hypertensive patients in the JATOS study.
Topics: Aged; Antihypertensive Agents; Chronic Disease; Dihydropyridines; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Diseases; Nitrophenols; Organophosphorus Compounds; Proteinuria; Randomized Controlled Trials as Topic | 2010 |
Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
Topics: Action Potentials; Animals; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Cricetinae; Depression, Chemical; Dihydropyridines; Heart Rate; In Vitro Techniques; Isomerism; Kinetics; Male; Nitrophenols; Organophosphorus Compounds; Patch-Clamp Techniques; Protein Isoforms; Protein Subunits; Rabbits; Recombinant Proteins; Sinoatrial Node | 2010 |
Is renal antiaging possible?
Topics: Aging; Antihypertensive Agents; Chronic Disease; Dihydropyridines; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Diseases; Nitrophenols; Organophosphorus Compounds; Randomized Controlled Trials as Topic | 2010 |
Inhibitory effects of T/L-type calcium channel blockers on tubulointerstitial fibrosis in obstructed kidneys in rats.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Fibrosis; Kidney Tubules; Male; Nifedipine; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Ureteral Obstruction | 2011 |
Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease.
Topics: Animals; Benzimidazoles; Cadmium; Calcium; Calcium Channels, T-Type; Cyclopropanes; Dihydropyridines; Disease Models, Animal; Electrophysiology; Male; Mibefradil; Movement; Naphthalenes; Neurons; Nickel; Nitrophenols; Organophosphorus Compounds; Parkinson Disease; Rats; Rats, Wistar | 2011 |
Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.
Topics: Adrenocortical Carcinoma; Angiotensin II; Bucladesine; Calcium Channel Blockers; Cell Line, Tumor; Dehydroepiandrosterone Sulfate; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Nitrophenols; Organophosphorus Compounds; Phosphoproteins; RNA, Messenger; Verapamil | 2011 |
Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Fibroblasts; Fibrosis; Myocardium; Nifedipine; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Smad2 Protein; Transfection; Transforming Growth Factor beta1 | 2011 |
Is metabolic syndrome a risk factor for cardiovascular disease in late elderly?
Topics: Blood Pressure; Cardiovascular Diseases; Dihydropyridines; Female; Humans; Hypertension; Male; Metabolic Syndrome; Nitrophenols; Organophosphorus Compounds | 2011 |
Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine.
Topics: Animals; Antihypertensive Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biocatalysis; Biological Availability; Blood Glucose; Carbamates; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydropyridines; Drug Interactions; Humans; Hypoglycemic Agents; Ketoconazole; Male; Models, Biological; Nitrophenols; Organophosphorus Compounds; Pharmacological Phenomena; Piperidines; Rats; Rats, Sprague-Dawley; Rhodamine 123 | 2012 |
T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice.
Topics: Animals; Azoles; Base Sequence; beta-Thalassemia; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiovascular System; Deferoxamine; Dihydropyridines; Disease Models, Animal; DNA Primers; Heart Rate; Humans; Iron; Iron Chelating Agents; Iron, Dietary; Isoindoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Nifedipine; Nitrophenols; Organ Size; Organophosphorus Compounds; Organoselenium Compounds; RNA, Messenger; Ventricular Function, Left; Verapamil | 2012 |
Role of specific T-type calcium channel blocker R(-) efonidipine in the regulation of renal medullary circulation.
Topics: Angiotensin II; Animals; Blood Flow Velocity; Calcium Channel Blockers; Calcium Channels, T-Type; Dihydropyridines; Disease Models, Animal; Drug Antagonism; Infusions, Intravenous; Ischemia; Kidney Medulla; Laser-Doppler Flowmetry; NG-Nitroarginine Methyl Ester; Nitrogen Dioxide; Nitrogen Oxides; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasoconstrictor Agents | 2012 |
Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels.
Topics: Animals; Azoles; beta-Thalassemia; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, T-Type; Cation Transport Proteins; Cell Survival; Cells, Cultured; Deferoxamine; Dihydropyridines; Disease Models, Animal; Ferric Compounds; Heart Ventricles; Iron Overload; Isoindoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Nitrophenols; Organophosphorus Compounds; Organoselenium Compounds; Quaternary Ammonium Compounds; Receptors, Transferrin; Verapamil | 2013 |
A molecular signature of tissues with pacemaker activity in the heart and upper urinary tract involves coexpressed hyperpolarization-activated cation and T-type Ca2+ channels.
Topics: Animals; Dihydropyridines; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Immunohistochemistry; Kidney; Mice; Muscle Contraction; Muscle, Smooth; Nitrophenols; Organophosphorus Compounds; Peristalsis; Urinary Tract | 2014 |
Determination of efonidipine in human plasma by LC-MS/MS for pharmacokinetic applications.
Topics: Adult; Calcium Channel Blockers; Chromatography, Liquid; Dihydropyridines; Female; Humans; Limit of Detection; Male; Nitrophenols; Organophosphorus Compounds; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Young Adult | 2015 |
Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
Topics: Animals; Benzoates; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiovascular Diseases; Deferasirox; Deferiprone; Deferoxamine; Dihydropyridines; Heart; Iron Chelating Agents; Iron Overload; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mitochondria; Nitrophenols; Organophosphorus Compounds; Pyridones; Thalassemia; Triazoles | 2016 |
A chiral LC-MS/MS method for the stereospecific determination of efonidipine in human plasma.
Topics: Administration, Oral; Chromatography, Liquid; Dihydropyridines; Humans; Liquid-Liquid Extraction; Nitrophenols; Organophosphorus Compounds; Plasma; Stereoisomerism; Tablets; Tandem Mass Spectrometry | 2016 |
Solid dispersions of efonidipine hydrochloride ethanolate with improved physicochemical and pharmacokinetic properties prepared with microwave treatment.
Topics: Animals; Area Under Curve; Calorimetry, Differential Scanning; Dihydropyridines; Dogs; Drug Carriers; Hot Temperature; Magnetic Resonance Spectroscopy; Male; Methylcellulose; Microwaves; Nitrophenols; Organic Chemicals; Organophosphorus Compounds; Solubility; Solvents; Urea; X-Ray Diffraction | 2016 |
Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
Topics: Aminophylline; Animals; Apoptosis; Atropine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, T-Type; Deferiprone; Dihydropyridines; Drug Combinations; Heart; Heart Rate; Iron; Iron Chelating Agents; Iron Overload; Male; Malondialdehyde; Mice; Mitochondria; Myocardium; Nitroglycerin; Nitrophenols; Organelle Biogenesis; Organophosphorus Compounds; Oxidative Phosphorylation; Papaverine; Phenobarbital; Pyridones; Signal Transduction; Thalassemia | 2017 |
Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet-milling method.
Topics: Animals; Area Under Curve; Arginine; Biological Availability; Calcium Channel Blockers; Chemistry, Pharmaceutical; Dihydropyridines; Excipients; Hydrogen-Ion Concentration; Male; Nanoparticles; Nitrophenols; Organophosphorus Compounds; Poloxamer; Rats; Rats, Sprague-Dawley; Sodium Dodecyl Sulfate; Solubility; Suspensions; Tablets | 2018 |
Structural basis for efonidipine block of a voltage-gated Ca
Topics: Arcobacter; Calcium Channel Blockers; Calcium Channels; Crystallography, X-Ray; Dihydropyridines; Humans; Models, Molecular; Nitrophenols; Organophosphorus Compounds; Protein Conformation | 2019 |
Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Deferiprone; Dihydropyridines; Disease Models, Animal; Iron; Iron Chelating Agents; Iron Overload; Mice; Mice, Inbred C57BL; Neurotoxicity Syndromes; Nitrophenols; Organophosphorus Compounds; Thalassemia | 2019 |
Role Of Efonidipine In CKD Patients : A Study in North Bihar.
Topics: Dihydropyridines; Humans; Nitrophenols; Organophosphorus Compounds; Renal Insufficiency, Chronic | 2020 |
In Vitro-In Vivo Correlation for Solid Dispersion of a Poorly Water-Soluble Drug Efonidipine Hydrochloride.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; In Vitro Techniques; Male; Nitrophenols; Organophosphorus Compounds; Pharmaceutical Preparations; Rats; Rats, Sprague-Dawley; Solubility; Solvents; Water | 2020 |
Zonisamide can ameliorate the voltage-dependence alteration of the T-type calcium channel Ca
Topics: Calcium Channels, T-Type; Dihydropyridines; Electrophysiological Phenomena; HEK293 Cells; Humans; Mutation; Nitrophenols; Organophosphorus Compounds; Spinocerebellar Ataxias; Zonisamide | 2020 |
Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study.
Topics: Antiviral Agents; Binding Sites; Computer Simulation; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Databases, Protein; Diarylquinolines; Dihydropyridines; Humans; Indoles; Leucine; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Nitrobenzenes; Nitrophenols; Organophosphorus Compounds; Piperazines; Proline; Protease Inhibitors; Pyrrolidinones; SARS-CoV-2 | 2021 |
Efonidipine Exerts Cerebroprotective Effect by Down-regulation of TGF-β/SMAD-2-Dependent Signaling Pathway in Diabetic Rats.
Topics: Acetylcholinesterase; Animals; Brain; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Dihydropyridines; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Neuroprotective Agents; Nitrites; Nitrophenols; Organophosphorus Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2021 |